NextCure, Inc. financial data

Symbol
NXTC on Nasdaq
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 717 % -43.3%
Debt-to-equity 25.4 % +78.7%
Return On Equity -108 % -86.7%
Return On Assets -85.2 % -68.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.68M shares -90.4%
Common Stock, Shares, Outstanding 2.34M shares -91.6%
Common Stock, Value, Issued 2K USD -92.9%
Weighted Average Number of Shares Outstanding, Basic 2.37M shares +1.87%
Weighted Average Number of Shares Outstanding, Diluted 2.37M shares +1.87%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 49.7M USD +6.44%
General and Administrative Expense 14.2M USD -16.5%
Operating Income (Loss) -63.9M USD +3.54%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -60.9M USD +0.57%
Earnings Per Share, Basic -6 USD/shares +21.8%
Earnings Per Share, Diluted -6 USD/shares +21.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.89M USD -76.5%
Assets, Current 40M USD -55.8%
Property, Plant and Equipment, Net 4.17M USD -37.7%
Operating Lease, Right-of-Use Asset 2.95M USD -17.2%
Other Assets, Noncurrent 555K USD -70.4%
Assets 47.7M USD -53.5%
Accounts Payable, Current 2.54M USD -49.9%
Employee-related Liabilities, Current 1.75M USD +76.7%
Liabilities, Current 10.8M USD -0.48%
Operating Lease, Liability, Noncurrent 4.67M USD -16.5%
Other Liabilities, Noncurrent 596K USD -17.8%
Liabilities 16M USD -6.44%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD +91.9%
Retained Earnings (Accumulated Deficit) -418M USD -17.1%
Stockholders' Equity Attributable to Parent 29.6M USD -65.3%
Liabilities and Equity 47.7M USD -53.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13M USD -3.08%
Net Cash Provided by (Used in) Investing Activities 7.09M USD -60.3%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.34M shares -91.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.9M USD -212%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.89M USD -76.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 16K USD -15.8%
Deferred Tax Assets, Valuation Allowance 115M USD +16.5%
Deferred Tax Assets, Gross 116M USD +16%
Operating Lease, Liability 5.59M USD -11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.8M USD -0.68%
Lessee, Operating Lease, Liability, to be Paid 6.69M USD -14.6%
Property, Plant and Equipment, Gross 28.6M USD -2.42%
Operating Lease, Liability, Current 796K USD +21.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.36M USD +11.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.1M USD -28.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.44M USD +3.01%
Deferred Tax Assets, Operating Loss Carryforwards 63.6M USD +12.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.48M USD +2.99%
Operating Lease, Payments 285K USD +2.89%
Additional Paid in Capital 448M USD +1.15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.06M USD -23%
Share-based Payment Arrangement, Expense 5M USD -31.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%